BGNE BeiGene Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: BGNE

Price (delayed)

$148.56

Market cap

$15.55B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.65

Enterprise value

$13.3B

Highlights
The company's gross profit has surged by 84% YoY and by 12% QoQ
The revenue has soared by 74% YoY and by 12% from the previous quarter
BeiGene's debt has soared by 60% from the previous quarter and by 56% YoY
BeiGene's quick ratio has decreased by 39% YoY and by 28% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.beigene.com/
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of BGNE
Market
Shares outstanding
104.68M
Market cap
$15.55B
Enterprise value
$13.3B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.4
Price to sales (P/S)
6.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.41
Earnings
Revenue
$2.46B
EBIT
-$899.85M
EBITDA
-$812.17M
Free cash flow
-$1.72B
Per share
EPS
-$0.65
Free cash flow per share
-$16.45
Book value per share
$33.79
Revenue per share
$23.53
TBVPS
$55.01
Balance sheet
Total assets
$5.81B
Total liabilities
$2.27B
Debt
$930.19M
Equity
$3.54B
Working capital
$2.39B
Liquidity
Debt to equity
0.26
Current ratio
2.32
Quick ratio
1.96
Net debt/EBITDA
2.77
Margins
EBITDA margin
-33%
Gross margin
84.5%
Net margin
-35.9%
Operating margin
-49.1%
Efficiency
Return on assets
-15.3%
Return on equity
-23.1%
Return on invested capital
-54.7%
Return on capital employed
-22.5%
Return on sales
-36.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BGNE stock price

How has the BeiGene stock price performed over time
Intraday
3.08%
1 week
12.58%
1 month
-3.48%
1 year
-39.8%
YTD
-17.63%
QTD
-5.01%

Financial performance

How have BeiGene's revenue and profit performed over time
Revenue
$2.46B
Gross profit
$2.08B
Operating income
-$1.21B
Net income
-$881.71M
Gross margin
84.5%
Net margin
-35.9%
The company's gross profit has surged by 84% YoY and by 12% QoQ
BeiGene's net margin has soared by 75% YoY and by 17% from the previous quarter
The revenue has soared by 74% YoY and by 12% from the previous quarter
BGNE's operating margin has surged by 61% year-on-year and by 16% since the previous quarter

Growth

What is BeiGene's growth rate over time

Valuation

What is BeiGene stock price valuation
P/E
N/A
P/B
4.4
P/S
6.31
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.41
The company's EPS has surged by 56% YoY and by 8% QoQ
The price to book (P/B) is 23% lower than the 5-year quarterly average of 5.7 and 15% lower than the last 4 quarters average of 5.2
The equity has contracted by 19% YoY and by 6% from the previous quarter
BGNE's price to sales (P/S) is 78% lower than its 5-year quarterly average of 28.5 and 38% lower than its last 4 quarters average of 10.2
The revenue has soared by 74% YoY and by 12% from the previous quarter

Efficiency

How efficient is BeiGene business performance
The company's return on sales has surged by 74% YoY and by 18% QoQ
The company's return on assets rose by 46% YoY and by 6% QoQ
BeiGene's ROIC has increased by 43% YoY and by 10% from the previous quarter
BGNE's return on equity is up by 42% year-on-year and by 2.9% since the previous quarter

Dividends

What is BGNE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BGNE.

Financial health

How did BeiGene financials performed over time
The total assets is 156% greater than the total liabilities
BeiGene's quick ratio has decreased by 39% YoY and by 28% QoQ
The current ratio is down by 35% year-on-year and by 27% since the previous quarter
BeiGene's debt is 74% less than its equity
BeiGene's debt to equity has surged by 86% YoY and by 73% QoQ
BeiGene's debt has soared by 60% from the previous quarter and by 56% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.